OHR

What OHR does

OHR is a deep-tech industrial chemistry company developing Creationary Chemistry™, a proprietary manufacturing platform that merges biological intelligence with primordial chemistry to enable programmable, non-oil-dependent production of critical chemicals. The company targets industrial partners seeking supply security and sovereignty, positioning its offering as an alternative to geopolitically sensitive, petrochemical-based supply chains for essential chemistry. The platform is built around three value themes — Essential Chemistry, Supply Secured, and Chemistry Programmed — and is described as science engineered for scale, with messaging spanning applications from rocket propellants to industrial feedstocks.

The company operates across three offices in San Diego, Tel Aviv, and Chicago, with a nine-person team led by Founder and CEO Dan Davidi alongside Chief Manufacturing Officer Julie Zarraga, Chief Technology Officer Dave Wernick, and Head of Narrative & Alliances Brachie Sprung. OHR is a privately held, venture-backed company with disclosed investors including Aleph, Deep33 Ventures, Standard Industries, KDM Partners, Yasmin Lukatz, 202 Ventures, and Clocktower Ventures. Founded in 2024, OHR has not publicly disclosed funding amounts, customer logos, revenue, or commercial-scale product launches.

OHR's go-to-market is partnership-driven and enterprise-focused rather than product-distribution-led. Revenue mechanics are not disclosed but are characterized as recurring, with pricing likely negotiated per industrial partnership. The primary customer segment is industrial partners requiring secured, sovereign supply of critical chemicals; no named customers or reference accounts are publicly listed. Distribution is handled through direct enterprise engagement, supported by a narrative and alliances function that signals deliberate emphasis on strategic relationship development over broad marketing.

Name

OHR

Legal name

OHR

Website

https://ohr.bio

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

OHR is a deep-tech industrial chemistry company developing Creationary Chemistry™, a manufacturing platform that merges biological intelligence with primordial chemistry to produce critical chemicals independent of oil-based feedstocks. It serves industrial partners seeking supply security and sovereignty.

Ownership category

akta.pro rank

Product category

Industrial Specialty Chemicals Manufacturing

NAICS

Chemical Manufacturing (325)

SIC

Chemicals & Allied Products (2800)

akta.pro primary industry

Custom Intermediates & Advanced Intermediates Manufacturing (HLAGAHAH)

Keywords

• Industrial chemical manufacturing
• Programmable chemistry
• Bio-based chemicals
• Supply chain sovereignty
• Critical chemicals production

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Chemical Manufacturing & Licensing: OHR appears to generate revenue through the design and manufacture of critical chemicals for industrial partners, with potential licensing of its proprietary Creationary Chemistry™ platform. The company positions itself as delivering essential chemistry that strengthens supply security and sovereignty for partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

OHR designs and manufactures critical chemicals through Creationary Chemistry™, a proprietary manufacturing logic that merges biological intelligence with primordial chemistry. The company produces essential industrial chemicals designed to operate independently of traditional oil-based feedstocks, providing partners with supply security and sovereignty. Offerings are built around partner-specific needs, leveraging local resources for industrial-scale chemical production.

Product overview

OHR offers a single unified product approach called Creationary Chemistry™ — a new way to design and manufacture critical chemicals. The company positions itself around three value themes: Essential Chemistry (chemistry that industry depends on), Supply Secured (strengthening supply, security, and sovereignty), and Chemistry Programmed (programmable chemistry for industrial independence). The offering merges biological intelligence with primordial chemistry to enable a cleaner, smarter, more sovereign industrial world.

Differentiator

Problem solved

Functional benefit

Products and services

• Creationary Chemistry™

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• BASF: BASF is the world's largest chemical producer with deep capabilities across the 'critical chemicals' OHR targets, representing the entrenched incumbent OHR must displace or differentiate against in industrial chemical supply.
• LyondellBasell: LyondellBasell is one of the largest petrochemical producers globally, with significant assets in olefins, polyolefins, and intermediates — the exact industrial chemistry segments OHR aims to provide alternative, non-oil-based routes for.
• Dow: Dow is a major integrated chemicals producer serving industrial partners globally; OHR's pitch around supply sovereignty and programmable chemistry directly targets Dow's market position in commodity and specialty industrial chemicals.

Direct peers

• Amyris: Amyris used engineered yeast to produce specialty chemicals and ingredients at industrial scale, representing a cautionary precedent for OHR in the bio-based specialty chemicals space — similar business model, similar scale-up challenges.
• Ginkgo Bioworks: Ginkgo operates a synthetic biology platform for programming cells to produce industrial chemicals, flavors, fragrances, and other molecules — analogous to OHR's 'programmable chemistry' positioning and biology-plus-manufacturing platform approach.
• LanzaTech: LanzaTech uses gas-fermenting microbes to produce fuels and chemicals from industrial waste gases, sharing OHR's biological-route-to-industrial-chemicals positioning and similar decarbonization and supply-security value proposition.
• Solugen: Solugen develops bio-based specialty chemicals using enzymatic processes, directly competing with OHR's biology-plus-chemistry manufacturing model for industrial chemical applications such as water treatment, cleaners, and concrete additives.

Emerging players

• Carbios: Carbios uses engineered enzymes for biorecycling of PET and producing bio-based monomers, sharing OHR's biology-enabled chemistry approach and addressing industrial-scale chemical production via biological routes.
• Novomer: Novomer developed catalytic processes to convert waste carbon feedstocks into specialty chemicals and polymers, conceptually aligned with OHR's mission of decoupling industrial chemistry from traditional oil-based feedstocks.

Others

• Standard Industries: Standard Industries is a large industrial conglomerate and an existing OHR investor, providing relevant context as both a strategic backer and a potential off-take / co-development partner across chemicals, building products, and adjacent materials.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/ohr-bio

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OHR